Background: The efficacy of interferon beta (IFN beta) is well established in relapsing-remitting multiple ... Although the reduction in the relapse rate was similar for all three commercial products, ...
Revolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market SAN DIEGO, CA / ACCESS Newswire / January 27, 2025 / Ainos, Inc.